China Series
May 26, 2015
On March 25, the Securities and Exchange Commission (the “Commission”) formally adopted final rules, which update and expand Regulation A, an exemption from the registration requirements mandated by the Securities Act of 1933 (the “Securities Act”). These newly adopted rules, which have been dubbed “Reg. A+, provide an exemption for small offerings of up to $50 million worth of securities in any one year period.
Continue reading
China Series
July 17, 2012
The past year has seen a number of developments in the U.S. markets that will affect small-cap companies and their ability to access the capital markets. Depending upon your perspective, these developments can be viewed as either positive or negative. The most substantive of these changes are the JOBS Act (Jumpstart Our Business Startups Act ) and the seasoning rules that relate to the ability of companies that have become public through reverse mergers with public shells to up-list their securities to a listed exchange such as NYSE-Amex or a national market such as NASDAQ.
Continue reading
China Series
April 25, 2012
As our previous articles have discussed, as a result of a number of factors, including negative allegations from short sellers and suspicion from regulators, Chinese companies with stock that trades publicly in the U.S. have faced unprecedented challenges in the last 18 months. Among these challenges, for companies whose stock is traded on Nasdaq or listed on the NYSE-AMEX, is the potential for delisting from these premier markets.
Continue reading
China Series
April 11, 2012
As discussed in previous articles, the past year has been largely negative for U.S. listed Chinese companies. As a result of numerous accounting scandals and allegations by short sellers, many U.S. listed Chinese companies have undertaken an independent investigation at the requests of either their independent auditor and/or the audit committee of the company’s board of directors.
Continue reading
China Series
April 11, 2012
As discussed in previous articles, the past year has been largely negative for U.S. listed Chinese companies. As a result of numerous accounting scandals and allegations by short sellers, many U.S. listed Chinese companies have undertaken an independent investigation at the requests of either their independent auditor and/or the audit committee of the company’s board of directors.
Continue reading
China Series
March 20, 2012
For Chinese companies that went public in the U.S. markets prior to 2011, particularly those that became public through an RTO, the ability to raise money in the U.S. capital markets has declined significantly since a number of high profile fraud allegations were made by various short sellers in the past two years. These allegations started a landslide of negative consequences for many Chinese companies listed in the U.S., including but not limited to, delisting of companies’ stock from markets such as Nasdaq and NYSE-AMEX, regulatory investigations and class action law suits.
Continue reading